Bone and the hematopoietic and immune systems: A report of the proceedings of a scientific workshop

Journal of Bone and Mineral Research

Volumn 13, Issue 4, 1998, Pages 537-543

  Sharrock, William J ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DEVELOPMENT; BONE MARROW; CELL LINEAGE; CONFERENCE PAPER; ENCHONDRAL OSSIFICATION; HEMATOPOIETIC SYSTEM; HUMAN; IMMUNE SYSTEM; LYMPHOPOIESIS; NONHUMAN; OSTEOCLAST; STROMA CELL;

ANIMALS; BONE DEVELOPMENT; HEMATOPOIETIC SYSTEM; HUMANS; IMMUNE SYSTEM; IMMUNE SYSTEM DISEASES; IMMUNITY, NATURAL; LYMPHOCYTES; MICE; OSTEOBLASTS; OSTEOCLASTS; STROMAL CELLS;

EID: 0031954956     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1998.13.4.537     Document Type: Conference Paper

References (28)

1. Jacenko O, Ito S, Olsen BR 1996 Skeletal and hematopoietic defects in mice transgenic for collagen X. Ann NY Acad Sci 785:278-280.
2. Schneider GB, Benis KA, Flay NW, Ireland RA, Popoff SN 1995 Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations. Bone 16:657-662.
3. Key LL Jr, Rodriguiz RM, Willi SM, Wright NM, Hatcher HC, Eyre DR, Cure JK, Griffin PP, Ries WL 1995 Long-term treatment of osteopetrosis with recombinant human interferon gamma. N Engl J Med 332:1594-1599.
4. Gowen M, Nedwin GE, Mundy GR 1986 Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gamma. J Bone Miner Res 1:469-474.
5. Kurihara N, Roodman GD 1990 Interferons-alpha and -gamma inhibit interleukin-1 beta-stimulated osteoclast-like cell formation in long-term human marrow cultures. J Interferon Res 10:541-547.
6. Mann GN, Jacobs TW, Buchinsky FJ, Armstrong EC, Li M, Ke HZ, Ma YF, Jee WS, Epstein S 1994 Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia. Endocrinology 135:1077-1083.
7. Nii A, Reynolds DA, Young HA, Ward JM 1997 Osteochondrodysplasia occurring in transgenic mice expressing interferon-gamma. Vet Pathol 34:431-441.
8. Weber GF, Ashkar S, Glimcher MJ, Cantor H 1996 Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509-512.
9. + fraction of adult human bone marrow contains the osteogenic precursors. Blood 84:4164-4173.
10. Matayoshi A, Brown C, DiPersio JF, Haug J, Abu-Amer Y, Liapis H, Kuestner R, Pacifici R 1996 Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells. Proc Natl Acad Sci USA 93: 10785-10790.
11. Jacobsen K, Kravitz J, Kincade PW, Osmond DG 1996 Adhesion receptors on bone marrow stromal cells: In vivo expression of vascular cell adhesion molecule-1 by reticular cells and sinusoidal endothelium in normal and gamma-irradiated mice. Blood 87:73-82.
12. Gupta P, McCarthy JB, Verfaillie CM 1996 Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells. Blood 87:3229-3236.
13. Taichman RS, Reilly MJ, Emerson SG 1996 Human osteoblasts support human hematopoietic progenitor cells in vitro bone marrow cultures. Blood 87:518-524.
14. Shevde N, Anklesaria P, Greenberger JS, Bleiberg I, Glowacki J 1994 Stromal cell-mediated stimulation of osteoclastogenesis. Proc Soc Exp Biol Med 205:306-315.
15. Herbertson A, Aubin JE 1995 Dexamethasone alters the subpopulation make-up of rat bone marrow stromal cell cultures. Bone Miner Res 10:285-294.
16. Canalis E 1996 Mechanisms of glucocorticoid action in bone: Implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81:3441-3447.
17. Dempster DW, Moonga BS, Stein LS, Horbert WR, Antakly T 1997 Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis. J Endocrinol 154:397-406.
18. Shen V, Birchman R, Liang XG, Wu DD, Lindsay R, Dempster DW 1997 Prednisolone alone, or in combination with estrogen or dietary calcium deficiency or immobilization, inhibits bone formation but does not induce bone loss in mature rats. Bone 21:345-351.
19. Defranco DJ, Lian JB, Glowacki J 1992 Differential effects of glucocorticoid on recruitment and activity of osteoclasts induced by normal and osteocalcin-deficient bone implanted in rats. Endocrinology 131:114-121.
20. Buchinsky FJ, Ma Y, Mann GN, Rucinski B, Bryer HP, Romero DF, Jee WS, Epstein S 1996 T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia. Endocrinology 137:2278-2285.
21. Buchinsky FJ, Ma Y, Mann GN, Rucinski B, Bryer HP, Paynton BV, Jee WS, Hendy GN, Epstein S 1995 Bone mineral metabolism in T lymphocyte-deficient and -replete strains of rat. J Bone Miner Res 10:1556-1565.
22. Sass DA, Liss T, Bowman AR, Rucinski B, Popoff SN, Pan Z, Ma YF, Epstein S 1997 The role of the T-lymphocyte in estrogen deficiency osteopenia. J Bone Miner Res 12:479-486.
23. Lewis DB, Liggitt HD, Effmann EL, Motley ST, Teitelbaum SL, Jepsen KJ, Goldstein SA, Bonadio J, Carpenter J, Perlmutter RM 1993 Osteoporosis induced in mice by overproduction of interleukin 4. Proc Natl Acad Sci USA 90:11618-11622.
24. Udagawa N, Horwood NJ, Elliott J, Mackay A, Owens J, Okamura H, Kurimoto M, Chambers TJ, Martin TJ, Gillespie MT 1997 Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J Exp Med 185:1005-1012.
25. Shafritz AB, Shore EM, Gannon FH, Zasloff MA, Taub R, Muenke M, Kaplan FS 1996 Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med 335:555-561.
26. Long MW, Robinson JA, Ashcraft EA, Mann KG 1995 Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J Clin Invest 95:881-887.
27. Smithson G, Medina K, Ponting I, Kincade PW 1995 Estrogen suppresses stromal cell-dependent lymphopoiesis in culture. J Immunol 155:3409-3417.
28. Ware CB, Horowitz MC, Renshaw BR, Hunt JS, Liggitt D, Koblar SA, Gliniak BC, McKenna HJ, Papayannopoulou T, Thoma B, Cheng L, Donovan PJ, Peschon J, Bartlett PF, Willis CR, Wright BD, Carpenter MK, Davison BL, Gearing DP 1995 Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 121:1283-1299.